Pharmaceutical Outsourcing covers news of importance to the contract services segment of the pharmaceutical industry.
Collected from the most trusted on-line resources, these news stories are chosen and published here based on their relevance to the pharmaceutical industry.
Topics of interest typically include: mergers and acquisitions, service additions, new capabilities, personnel changes, news from the FDA and other international regulatory and standard-setting agencies, and new outsourcing contracts and deals.
If you are looking to stay up-to-date with the news in your industry, this resource is vital for your industry knowledge.
ISPE, the International Society for Pharmaceutical Engineering, announced today that it will work with stakeholders world-wide to produce a Drug Shortages Prevention Plan to guide the pharmaceutical and biopharmaceutical industry in establishing ...
read more
Wednesday, April 25, 2012
ISPE announced today the Food and Drug Administration (FDA) will co-sponsor the upcoming “Redefining the ‘C’ in ‘CGMP’” Conference in Baltimore, Md. USA on 4 – 5 June 2012. The conference is the first joint ISPE-FDA conference focused on CGMP issues.
read more
At the 3rd annual ISPE-FDA CGMP Conference, ISPE announced the official launch of its Metrics Pilot Program. The launch of the pilot, headed by ISPE’s PQLI® Quality Metrics Team, is a major milestone in the overall project from ISPE. The pilot is now...
read more
Tuesday, November 23, 2021
iSpecimen Inc., an online marketplace for human biospecimens, today announced that it has been contracted to support new advanced research on COVID-19 seeking insights on its transmissibility, variants, outcomes, and testing validity among multiple ...
read more
IVERIC bio and Catalent Biologics have entered into an agreement for production and manufacturing of GMP-grade AAV vector for IVERIC bio’s gene therapy product candidates, IC-100.
read more
Thursday, December 14, 2017
Izana Bioscience has launched as a new clinical-stage translational medicine company.
read more
Jacobs has been selected to provide EPCMCQV to retrofit AstraZeneca’s West Chester, Ohio manufacturing facility to deliver a potential vaccine to fight the COVID-19 virus.
read more
Wednesday, November 27, 2019
JanOne has announced a licensing agreement for TV1001SR, a treatment for Peripheral Artery Disease.
read more
Thursday, February 06, 2020
JanOne has executed a manufacturing agreement for the formulation and manufacturing of TV1001SR, a treatment for Peripheral Artery Disease.
read more
JanOne has successfully completed the formulation of JAN101, its potential treatment for Peripheral Artery Disease expected to soon be in Phase 2b trials.
read more
Friday, September 04, 2020
JanOne has confirmed stability of its developmental batch run of JAN101.
read more
JanOne has selected its bottling and labeling partner to support upcoming clinical trials.
read more
Friday, February 27, 2015
Japan’s pharmaceutical market value is set to grow at a tepid Compound Annual Growth Rate (CAGR) of 1.3% from $72.8 billion in 2013 to reach $79.8 billion by 2020, driven by new product launches and the healthcare burden of the country’s aging ...
read more
Friday, February 25, 2022
Hovione announced that the Board of Directors and the shareholders have approved the appointment of Dr. Jean-Luc Herbeaux as Hovione’s Chief Executive Officer, effective 1st April 2022.
read more
Thursday, January 03, 2013
JHP Pharmaceuticals, LLC (“JHP”), a specialty pharmaceutical company that acquires, develops, manufactures and sells sterile injectable products, today announced that it has been acquired by an affiliate of Warburg Pincus, a leading global private ...
read more